Raymond James & Associates »

Axsome Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $705k 8.8k 79.80
2023-12-31 $431k 5.4k 79.59
2023-09-30 $382k 5.5k 69.89
2023-06-30 $580k 8.1k 71.86
2023-03-31 $307k 5.0k 61.68
2022-12-31 $532k 6.9k 77.13
2022-09-30 $264k 5.9k 44.59
2022-06-30 $226k 5.9k 38.27
2022-03-31 $233k 5.6k 41.39
2021-12-31 $205k 5.4k 37.73
2021-06-30 $481k 7.1k 67.42
2021-03-31 $217k 3.8k 56.57
2020-12-31 $313k 3.8k 81.60
2020-09-30 $285k 4.0k 71.20
2020-06-30 $329k 4.0k 82.19
2020-03-31 $251k 4.3k 58.82
2019-12-31 $793k 7.7k 103.32
2019-09-30 $473k 23k 20.24
2019-06-30 $653k 25k 25.74